Effects of hemodialysis and hypertonic hemodiafiltration on cardiac function compared

• Published in: Kidney international Vol. 32; no. 3; pp. 399 - 407
• Main Authors: Teo, Koon K., Basile, Carlo, Ulan, Raymond A., Hetherington, Maxine D., Kappagoda, Tissa
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01-09-1987; Nature Publishing
• Subjects: Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Biological and medical sciences; Emergency and intensive care: renal failure. Dialysis management; Intensive care medicine; Medical sciences; Human; Extrarenal dialysis; Cardiac performance; Hemodialysis; Hemofiltration; Resuscitation
• ISSN: 0085-2538; 1523-1755
• DOI: 10.1038/ki.1987.224

Effects of hemodialysis and hypertonic hemodiafiltration on cardiac function compared. This study compared the acute and chronic effects on cardiac function of treatment with hypertonic hemodiafiltration (H HDF) and hemodialysis (HD). Cardiac function was assessed before, during and after a run of H HDF and HD using echocardiography and impedance cardiography in 10 patients in a randomized cross-over sequence, two months after stabilization on each treatment. Blood biochemistry was performed before and after each run. Ejection fraction and fractional shortening were significantly higher before the H HDF run, compared to the HD run, and this difference persisted during and after the treatment runs (both P < 0.05). There was a corresponding significant difference in the increase of the velocity of circumferential fiber shortening and in the reduction of end systolic diameter during and after P HDF (P < 0.05). Heart rate, stroke volume, cardiac output, systemic vascular resistance and mean arterial pressure did not differ significantly between the two treatments. Plasma calcium and bicarbonate were significantly higher (P < 0.03) at the start of H HDF and this difference was enhanced at the end of the run. In conclusion, H HDF compared with HD, is associated with a better myocardial function in both the short and long term treatments. The evidence suggests that this may be due to improved levels of plasma calcium, bicarbonate, and/or the removal of an as yet unidentified myocardial toxin.